Biofrontera Inc. is a pharmaceutical company, specializing in high quality dermatological products for the care and treatment of skin diseases. Biofrontera’s primary focus is on the development and commercialization of novel therapies for non-melanoma skin cancer.
The entire team at Biofrontera consists of highly motivated and exceptionally committed people, aiming to provide high quality products and great service for doctors and their patients. Biofrontera headquarters are located in Leverkusen, Germany, and Biofrontera Inc. has its offices near Boston, MA.
Since its establishment in 1997, the company founder and chairman of the management board, Prof. Dr. Hermann Luebbert oversees the activities of the company. Biofrontera is the first German pharmaceutical start-up company to obtain centralized EU and recently US approval for a drug/ medical device developed in-house. Our products are marketed in 13 countries.
